Accelerate clinical entry without compromising rigor

Sponsors are under increasing pressure to reach the clinic faster, often with constrained budgets and complex global requirements. But speed cannot come at the expense of patient safety, regulatory confidence or scientific rigor. 

This IQVIA Insights Guide explores how a disciplined, question-based approach to regulatory efficiency can help teams evaluate whether each study is truly necessary, decision-driving and phase appropriate. It outlines how sponsors can use regulatory intelligence, prior knowledge, modeling and simulation, and early regulator engagement to right-size evidence packages and avoid unnecessary work.

Download the guide to explore:

  • How to evaluate proposed studies against safety, regulatory and decision-making needs
  • Where studies may be redesigned, deferred, replaced or eliminated
  • How prior knowledge, modeling, simulation and adaptive designs can support efficient development
  • How regulatory intelligence can help identify what is necessary and what is not
  • How early, transparent engagement with regulators can support clinical entry and global alignment
Checkboxes (copy)

© 2026 Marketing Masters Hub. All rights reserved.

Scroll to Top